Histone modification in psoriasis: Molecular mechanisms and potential therapeutic targets

被引:0
|
作者
Liu, Ruifeng [1 ]
Zhang, Luyao [2 ]
Zhang, Kaiming [1 ]
机构
[1] Shanxi Med Univ, Inst Dermatol, Shanxi Key Lab Stem Cells Immunol Dermatosis, Taiyuan Cent Hosp, 5 Dong San Dao Xiang, Taiyuan 030009, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Shanghai, Peoples R China
关键词
epigenetics; histone modification; molecular targets; psoriasis; T-CELLS; LYSINE METHYLATION; ACETYLATION; EPIGENETICS; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATE; INHIBITION; RESPONSES; H3;
D O I
10.1111/exd.15151
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is an immune-mediated, inflammatory disease. Genetic and environmental elements are involved in the nosogenesis of this illness. Epigenetic inheritance serves as the connection between genetic and environmental factors. Histone modification, an epigenetic regulatory mechanism, is implicated in the development of numerous diseases. The basic function of histone modification is to regulate cellular functions by modifying gene expression. Modulation of histone modification, such as regulation of enzymes pertinent to histone modification, can be an alternative approach for treating some diseases, including psoriasis. Herein, we reviewed the regulatory mechanisms and biological effects of histone modifications and their roles in the pathogenesis of psoriasis. This paper reviewed the regulatory mechanisms and biological effects of histone modifications and their roles in the pathogenesis of psoriasis. It highlights the role of epigenetic inheritance and the potential of targeting histone modification as an alternative therapeutic approach for psoriasis and other-related diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
    Bajbouj, Khuloud
    Al-Ali, Abeer
    Ramakrishnan, Rakhee K.
    Saber-Ayad, Maha
    Hamid, Qutayba
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [2] Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)
    Qu, Peng
    Li, Lanfang
    Jin, Qi
    Liu, Donghai
    Qiao, Yuan
    Zhang, Yijia
    Sun, Qiuyue
    Ran, Shuman
    Li, Zecheng
    Liu, Tongtong
    Peng, Liang
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 54 (05)
  • [3] Molecular Mechanisms and Potential Therapeutic Targets in Incisional Hernia
    Thankam, Finosh G.
    Palanikumar, Gunasekar
    Fitzgibbons, Robert J.
    Agrawal, Devendra K.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 134 - 143
  • [4] Molecular Mechanisms of Diabetic Retinopathy: Potential Therapeutic Targets
    Coucha, Maha
    Elshaer, Sally L.
    Eldahshan, Wael S.
    Mysona, Barbara A.
    El-Remessy, Azza B.
    [J]. MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2015, 22 (02) : 135 - 144
  • [5] Ovarian fibrosis: molecular mechanisms and potential therapeutic targets
    Gu, Mengqing
    Wang, Yibo
    Yu, Yang
    [J]. JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [6] RNA modification: mechanisms and therapeutic targets
    Lei Qiu
    Qian Jing
    Yanbo Li
    Junhong Han
    [J]. Molecular Biomedicine, 4
  • [7] RNA modification: mechanisms and therapeutic targets
    Qiu, Lei
    Jing, Qian
    Li, Yanbo
    Han, Junhong
    [J]. MOLECULAR BIOMEDICINE, 2023, 4 (01):
  • [8] IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
    Sue Han
    Yang Liu
    Sabrina J. Cai
    Mingyu Qian
    Jianyi Ding
    Mioara Larion
    Mark R. Gilbert
    Chunzhang Yang
    [J]. British Journal of Cancer, 2020, 122 : 1580 - 1589
  • [9] Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
    Jaster, Alaina M.
    Gonzalez-Maeso, Javier
    [J]. MOLECULAR PSYCHIATRY, 2023, 28 (09) : 3595 - 3612
  • [10] Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit
    McGee, Sean L.
    Hargreaves, Mark
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (09) : 495 - 505